Research programme: anti-infective monoclonal antibodies - Mapp Biopharmaceutical

Drug Profile

Research programme: anti-infective monoclonal antibodies - Mapp Biopharmaceutical

Alternative Names: Anti-Clostridium difficile monoclonal antibodies - Mapp; Antiviral monoclonal antibodies - Mapp; Junin virus anti-infective monoclonal antibodies - Mapp; Marburg virus anti-infective monoclonal antibodies - Mapp; Multi-antibody prevention product - Mapp/IPCP; Respiratory syncytial virus anti-infective monoclonal antibodies - Mapp; Venezuelan equine encephalitis antiviral monoclonal antibodies - Mapp

Latest Information Update: 23 Jan 2015

Price : *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Mapp Biopharmaceutical
  • Developer Baylor College of Medicine; Defence Research and Development Canada; Defence Science and Technology Laboratory; Iowa State University; Mapp Biopharmaceutical; Public Health Agency of Canada; The Scripps Research Institute; United States Army Medical Research Institute of Infectious Diseases; University of Texas Medical Branch
  • Class Antibacterials; Antivirals; Monoclonal antibodies
  • Mechanism of Action Undefined mechanism
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity Yes

Highest Development Phases

  • Preclinical Clostridium-difficile-infections; Junin virus infections; Marburg virus disease; Respiratory syncytial virus infections; Venezuelan equine encephalomyelitis

Most Recent Events

  • 23 Jan 2015 Preclinical trials in Clostridium difficile infections in USA (Parenteral)
  • 23 Jan 2015 Preclinical trials in Junin virus infections in USA (Parenteral)
  • 23 Jan 2015 Preclinical trials in Marburg virus disease in USA (Parenteral)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top